9+ hour, 36+ min ago   (134+ words) " The review provides strong scientific rationale to support Alto's drug development approach leveraging its Precision Psychiatry Platform " The authors further highlight a critical industry gap: the historical absence of translatable biomarkers that directly index plasticity changes in humans. Addressing this…...

2+ mon, 3+ week ago   (385+ words) Neurocrine Biosciences" investigational pill NBI-1070770or just "770was unable to significantly improve depression severity in a mid-stage study, slowing the momentum the biotech has built in recent weeks. In a brief announcement on Monday, Neurocrine announced that "770 "did not meet the primary…...

6+ mon, 3+ week ago   (880+ words) Over the past three weeks, psychedelics companies and investors have gotten their first look at two key readouts that could influence momentum in the space. Though the notably different market impacts of these announcements came as a surprise to some,…...